Stephen Spurgeon, MD

Oregon Health and Science University

Poster(s):

• 1432 - Title: A phase Ib study evaluating the safety and efficacy of tafasitamab, acalabrutinib, and obinutuzumab (TAO) in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma